Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma.
McCampbell
Adrienne S
AS
Broaddus
Russell R
RR
Walker
Cheryl L
CL
D000818:Animals; D002277:Carcinoma / Q000209:etiology* / Q000378:metabolism; D004195:Disease Models, Animal; D004714:Endometrial Hyperplasia / Q000150:complications* / Q000378:metabolism; D016889:Endometrial Neoplasms / Q000209:etiology* / Q000378:metabolism; D005260:Female; D006801:Humans; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism*; D000076222:Mechanistic Target of Rapamycin Complex 1; D046912:Multiprotein Complexes; D009765:Obesity / Q000150:complications / Q000378:metabolism; D010766:Phosphorylation; D011506:Proteins / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000378:metabolism
D055504:Insulin Receptor Substrate Proteins; D046912:Multiprotein Complexes; D011506:Proteins; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; D000076222:Mechanistic Target of Rapamycin Complex 1; D058570:TOR Serine-Threonine Kinases